Randomized, Investigator-Blinded Study to Compare the Efficacy and Tolerance of a 650-microsecond, 1064-nm YAG Laser to a 308-nm Excimer Laser for the Treatment of Mild to Moderate Psoriasis Vulgaris

Mark S. Nestor MD PhD,a,b Daniel Fischer DO MS,a David Arnold DOa

Current options for the treatment of psoriasis include systemic and topical modalities. Systemic therapies include immune inhibitors, immune modulators and, for moderate to severe disease, biological agents.1 Primarily, for mild to moderate psoriasis, topical treatments comprise ointments, medicated bath with diastase or herbal extracts, and phototherapy. Phototherapy is safe, effective, and does not incur the side effects of systemic medications.2

The 308-nm excimer laser is considered first-line phototherapy for topical plaque psoriasis.2 The efficacy and safety of this laser has been extensively evaluated for the treatment of psoriasis.3-9 The advantage of the excimer laser is its ability to treat psoriatic lesions with high doses of monochromatic radiation while sparing unaffected skin.2 Three protocols have been developed to optimize treatment: the minimal erythema dose, the induration, and the minimal blistering dose.7

A novel 650-microsecond 1064-nm Nd: YAG laser was introduced in 2009 by Khatri and colleagues who used the laser to remove unwanted hair.10 Since then, other investigators11, 12 have used the 650-microsecond laser to treat skin of color, onychomycosis,13 facial telangiectasias,14 and acne.15 The advantage of the 650-microsecond laser is that treatment does not require cooling or anesthesia because the pulse duration is shorter than or equal to the thermal relaxation time of the therapeutic target. This feature minimizes scarring, pigmentary changes, thermal damage to surrounding tissues, and discomfort during or after treatment.15

The 650-microsecond laser has received FDA approval for the treatment of psoriasis. The primary objective of this study was to compare the ability of the 650-microsecond, 1064-nm pulsed YAG laser (LightPod Neo®, Aerolase Corp., Tarrytown, NY) to clear psoriatic plaques with that of the 308-nm excimer laser (XTRAC Velocity 400®, PhotoMedex, Inc., Montgomeryville, PA). Plaques were located on the limbs of subjects with mild-to-moderate psoriasis vulgaris.

Table of Contents

Related Posts

Case Study with Joyce Ip

Skin Health of Tomorrow Intro and Overview Vibrant Dermatology Opened May 2018 1 Dermatologist & 4 extenders Patient population 50% Caucasian 50% Skin of Color

Case Study with Rene Shewalte

Aerolase Success Story Becoming Your Own Aesthetic Business Owner Inset Data Points (Practice at a Glance) Business: AAC by René opened May 2020 with one

Coffee Talk with Blair

Introduction: Blair Wegner has been working at Aspire Plastic Surgery & Med Spa as an Aesthetician for over 3 years. She is joined by 3

Dr. Nabil’s Testimonial

Introduction Dr. Nabil Fakih has spent many years studying Facial Plastic Surgery as a surgeon. In his studies, he became more aware of advanced therapeutic

Request Your Aerolase Demo Today!

Ready to Improve Skin Concerns
in a Whole New Way?

Not Ready? Stay updated with our Newsletter

Find out how Aerolase Can Grow Your Business